Induction of apoptosis in human cells by RNAi-mediated knockdown of hARD1 and NATH, components of the protein N-alpha-acetyltransferase complex
- PMID: 16518407
- DOI: 10.1038/sj.onc.1209469
Induction of apoptosis in human cells by RNAi-mediated knockdown of hARD1 and NATH, components of the protein N-alpha-acetyltransferase complex
Abstract
Protein N-epsilon-acetylation is recognized as an important modification influencing many biological processes, and protein deacetylase inhibitors leading to N-epsilon-hyperacetylation of histones are being clinically tested for their potential as anticancer drugs. In contrast to N-epsilon-acetyltransferases, the N-alpha-acetyltransferases transferring acetyl groups to the alpha-amino groups of protein N-termini have only been briefly described in mammalians. Human arrest defective 1 (hARD1), the only described human enzyme in this class, complexes with N-acetyltransferase human (NATH) and cotranslationally transfers acetyl groups to the N-termini of nascent polypeptides. Here, we demonstrate that knockdown of NATH and/or hARD1 triggers apoptosis in human cell lines. Knockdown of hARD1 also sensitized cells to daunorubicin-induced apoptosis, potentially pointing at the NATH-hARD1 acetyltransferase complex as a novel target for chemotherapy. Our results argue for an essential role of the NATH-hARD1 complex in cell survival and underscore the importance of protein N-alpha-acetylation in mammalian cells.
Similar articles
-
Characterization of hARD2, a processed hARD1 gene duplicate, encoding a human protein N-alpha-acetyltransferase.BMC Biochem. 2006 Apr 25;7:13. doi: 10.1186/1471-2091-7-13. BMC Biochem. 2006. PMID: 16638120 Free PMC article.
-
Identification and characterization of the human ARD1-NATH protein acetyltransferase complex.Biochem J. 2005 Mar 15;386(Pt 3):433-43. doi: 10.1042/BJ20041071. Biochem J. 2005. PMID: 15496142 Free PMC article.
-
The protein acetyltransferase ARD1: a novel cancer drug target?Curr Cancer Drug Targets. 2008 Nov;8(7):545-53. doi: 10.2174/156800908786241113. Curr Cancer Drug Targets. 2008. PMID: 18991565 Review.
-
Expression of N-acetyl transferase human and human Arrest defective 1 proteins in thyroid neoplasms.Thyroid. 2005 Oct;15(10):1131-6. doi: 10.1089/thy.2005.15.1131. Thyroid. 2005. PMID: 16279846
-
N-α-acetyltransferase 10 (NAA10) in development: the role of NAA10.Exp Mol Med. 2018 Jul 27;50(7):1-11. doi: 10.1038/s12276-018-0105-2. Exp Mol Med. 2018. PMID: 30054454 Free PMC article. Review.
Cited by
-
A splice donor mutation in NAA10 results in the dysregulation of the retinoic acid signalling pathway and causes Lenz microphthalmia syndrome.J Med Genet. 2014 Mar;51(3):185-96. doi: 10.1136/jmedgenet-2013-101660. Epub 2014 Jan 15. J Med Genet. 2014. PMID: 24431331 Free PMC article.
-
Cloning, characterization, and expression analysis of the novel acetyltransferase retrogene Ard1b in the mouse.Biol Reprod. 2009 Aug;81(2):302-9. doi: 10.1095/biolreprod.108.073221. Epub 2009 Feb 25. Biol Reprod. 2009. PMID: 19246321 Free PMC article.
-
Knockdown of NAT12/NAA30 reduces tumorigenic features of glioblastoma-initiating cells.Mol Cancer. 2015 Aug 21;14:160. doi: 10.1186/s12943-015-0432-z. Mol Cancer. 2015. PMID: 26292663 Free PMC article.
-
Drosophila variable nurse cells encodes arrest defective 1 (ARD1), the catalytic subunit of the major N-terminal acetyltransferase complex.Dev Dyn. 2010 Nov;239(11):2813-27. doi: 10.1002/dvdy.22418. Dev Dyn. 2010. PMID: 20882681 Free PMC article.
-
Characterization of hARD2, a processed hARD1 gene duplicate, encoding a human protein N-alpha-acetyltransferase.BMC Biochem. 2006 Apr 25;7:13. doi: 10.1186/1471-2091-7-13. BMC Biochem. 2006. PMID: 16638120 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources